comprehensive -WSS

comprehensive

author：focus 2025-09-30 20:27:13 - browse：924

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies.

In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study. That would have almost certainly led to a rejection by regulators, but Amylyx requested what’s called a re-examination of the opinion. On Tuesday, the EMA held a meeting on the appeal, and a decision is expected in the coming weeks.

“There are patients who are dying and they really want access to the drug,” said Evy Reviers, the chairwoman of the European Organization for Professionals and Patients with ALS, whose father has the neurological disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Amazon expands telehealth clinic nationwide

explore

WSS

SNAP should offer more nutrition education

The high personal cost of affirmative action for Black doctors

Mitch McConnell episode has important public health takeaway

In Spain, a hospital brews its own CAR

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Christmas in the PICU brings some surprising joy

focus

comprehensive

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Readout Newsletter: The latest on Moderna, Apellis, and Merck

ChatGPT in medicine: STAT answers readers' burning questions

‘Oppenheimer’ and the risks of AI in health care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Mega Millions pot grows to $1.25 billion after no winner

Drug repurposing or repositioning? The language matters

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Activists slam private health insurers over coverage restrictions

What the US credit downgrade means for the economy, your finances

explore

HCA sued by state AG for quality issues at Mission Health

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Adults seen as increasingly susceptible to measles

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

National panel will explore requiring free Covid tests

CRISPR gene editing developments we’re watching in 2024

entertainment

explore

leisure time

Wikipedia